In this preliminary study, TAMs were defined as cells isolated from 10 dpi ex vivo tumor specimens expressing CD45 but not expressing CD3; in our more extensive follow up study, however, we defined TAMs as cells expressing CD45 and CD11b, a marker for cells of myeloid lineage that includes monocytes, macrophages, and microglia (cells expressing these markers comprise potential antigen-presenting cells (APCs) within the tumor bed). The gene discussed is PTPRC; the disease is neoplasm.